We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Allogeneic Hematopoietic Cell Transplantation for Older Adults with Acute Myeloid Leukemia.
- Authors
Lipof, Jodi J.; Loh, Kah Poh; O’Dwyer, Kristen; Liesveld, Jane L.
- Abstract
Acute myeloid leukemia (AML) is a disease that affects adults aged 65 years and above, and survival in this population is poor. Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative therapy for these patients but is underutilized due to frequent comorbidities and perceived higher risk of treatment-related mortality and non-relapse mortality. Increasing data supports the utility of allo-HCT in fit older patients after intensive chemotherapy resulting in improvement of outcomes. With the development of reduced intensity and non-myeloablative conditioning regimens that are associated with lower rates of treatment-related toxicity and mortality, this has allowed more older patients with AML to receive allo-HCT. In this review, we provide some guidance on appropriate selection of older patients as transplant candidates, benefits and risks associated with allo-HCT, conditioning regimen choice, and stem cell transplant sources as they relate to the conduct of stem cell transplantation in older patients.
- Subjects
ACUTE myeloid leukemia treatment; GRAFT versus host disease; HEMATOPOIETIC stem cells; HEMATOPOIETIC stem cell transplantation; HOMOGRAFTS; ORGAN donors; TRANSPLANTATION of organs, tissues, etc.; DISEASE relapse; DISEASE remission; PATIENT selection; OLD age
- Publication
Cancers, 2018, Vol 10, Issue 6, p179
- ISSN
2072-6694
- Publication type
Article
- DOI
10.3390/cancers10060179